Company: BIAF
Filing Date: 2025-04-11
Form Type: S-1
Source: 0001641172-25-003892
Chunk: 75

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-11
Form: S-1
Chunk 75
---
 the interest of many brokerage firms
and analysts. We cannot give investors any assurance that an active public trading market for our Common Stock will develop or be sustained.
The market price of our Common Stock could be subject to wide fluctuations in response to quarterly variations in our revenues and operating
expenses, announcements of new products or services by us, significant sales of our Common Stock, including “short” sales,
the operating and stock price performance of other companies that investors may deem comparable to us, and news reports relating to trends
in our markets or general economic conditions.

An investment in our Company may involve tax implications, and you are encouraged to consult your own advisors as neither we nor any related party is offering any tax assurances or guidance regarding our Company or your investment.

An investment in our Company generally, involves complex
federal, state, and local income tax considerations. Neither the Internal Revenue Service nor any state or local taxing authority has
reviewed the transactions described herein and may take different positions than the ones contemplated by management. You are strongly
urged to consult your own tax and other advisors prior to investing, as neither we nor any of our officers, directors, or related parties
can offer tax or similar advice, nor are any such persons making any representations and warranties regarding such matters.

Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.

Under Section 382 of the Internal Revenue Code of
1986, as amended, if a corporation undergoes an “ownership change” (generally defined as a greater than 50% change (by value)
in its equity ownership over a three-year period), the corporation’s ability to use its pre-change net operating loss carryforwards
and other pre-change tax attributes (such as research tax credits) to offset its post-change income may be limited. We may experience
ownership changes in the future as a result of subsequent shifts in our stock ownership, including the completion of any offering taken
together with other transactions we may consummate in the succeeding three-year period. As a result, if we earn net taxable income, our
ability to use our pre-change net operating loss carryforwards to offset U.S. federal taxable income may be subject to limitations, which
potentially could result in increased future tax liability.

Our Certificate of Incorporation permits “blank check” Preferred Stock, which can be designated by our Board without stockholder approval.

We are authorized to issue 20,000,000 shares of Preferred
Stock. The shares of our